412 related articles for article (PubMed ID: 9561826)
1. Identification, origins and the diurnal role of the principal serine protease inhibitors in human tear fluid.
Sathe S; Sakata M; Beaton AR; Sack RA
Curr Eye Res; 1998 Apr; 17(4):348-62. PubMed ID: 9561826
[TBL] [Abstract][Full Text] [Related]
2. The serpin MNEI inhibits elastase-like and chymotrypsin-like serine proteases through efficient reactions at two active sites.
Cooley J; Takayama TK; Shapiro SD; Schechter NM; Remold-O'Donnell E
Biochemistry; 2001 Dec; 40(51):15762-70. PubMed ID: 11747453
[TBL] [Abstract][Full Text] [Related]
3. Interaction of secretory leukocyte protease inhibitor with proteinase-3.
Rao NV; Marshall BC; Gray BH; Hoidal JR
Am J Respir Cell Mol Biol; 1993 Jun; 8(6):612-6. PubMed ID: 8100709
[TBL] [Abstract][Full Text] [Related]
4. The novel bovine serpin endopin 2C demonstrates selective inhibition of the cysteine protease cathepsin L compared to the serine protease elastase, in cross-class inhibition.
Hwang SR; Stoka V; Turk V; Hook VY
Biochemistry; 2005 May; 44(21):7757-67. PubMed ID: 15909990
[TBL] [Abstract][Full Text] [Related]
5. Protease inhibitors derived from elafin and SLPI and engineered to have enhanced specificity towards neutrophil serine proteases.
Zani ML; Baranger K; Guyot N; Dallet-Choisy S; Moreau T
Protein Sci; 2009 Mar; 18(3):579-94. PubMed ID: 19241385
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of murine neutrophil serine proteinases by human and murine secretory leukocyte protease inhibitor.
Wright CD; Kennedy JA; Zitnik RJ; Kashem MA
Biochem Biophys Res Commun; 1999 Jan; 254(3):614-7. PubMed ID: 9920787
[TBL] [Abstract][Full Text] [Related]
7. Polymorphonuclear leukocyte cells and elastase in tears.
Sakata M; Sack RA; Sathe S; Holden B; Beaton AR
Curr Eye Res; 1997 Aug; 16(8):810-9. PubMed ID: 9255510
[TBL] [Abstract][Full Text] [Related]
8. Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes.
Sallenave JM; Shulmann J; Crossley J; Jordana M; Gauldie J
Am J Respir Cell Mol Biol; 1994 Dec; 11(6):733-41. PubMed ID: 7946401
[TBL] [Abstract][Full Text] [Related]
9. Regulation of secretory leukocyte proteinase inhibitor (SLPI) production by human bronchial epithelial cells: increase of cell-associated SLPI by neutrophil elastase.
van Wetering S; van der Linden AC; van Sterkenburg MA; Rabe KF; Schalkwijk J; Hiemstra PS
J Investig Med; 2000 Sep; 48(5):359-66. PubMed ID: 10979241
[TBL] [Abstract][Full Text] [Related]
10. Lysosomal enzymes from polymorphonuclear leukocytes and proteinase inhibitors in patients with cystic fibrosis.
Goldstein W; Döring G
Am Rev Respir Dis; 1986 Jul; 134(1):49-56. PubMed ID: 2425673
[TBL] [Abstract][Full Text] [Related]
11. Release of neutrophil proteinase 4(3) and leukocyte elastase during phagocytosis and their interaction with proteinase inhibitors.
Bergenfeldt M; Axelsson L; Ohlsson K
Scand J Clin Lab Invest; 1992 Dec; 52(8):823-9. PubMed ID: 1362620
[TBL] [Abstract][Full Text] [Related]
12. Influence of some natural and semisynthetic agents on elastase and cathepsin G from polymorphonuclear granulocytes.
Steinmeyer J; Kalbhen DA
Arzneimittelforschung; 1991 Jan; 41(1):77-80. PubMed ID: 1710897
[TBL] [Abstract][Full Text] [Related]
13. Cathepsin B, L, and S cleave and inactivate secretory leucoprotease inhibitor.
Taggart CC; Lowe GJ; Greene CM; Mulgrew AT; O'Neill SJ; Levine RL; McElvaney NG
J Biol Chem; 2001 Sep; 276(36):33345-52. PubMed ID: 11435427
[TBL] [Abstract][Full Text] [Related]
14. Inhibition by recombinant SLPI and half-SLPI (Asn55-Ala107) of elastase and cathepsin G activities: consequence for neutrophil-platelet cooperation.
Renesto P; Balloy V; Kamimura T; Masuda K; Imaizumi A; Chignard M
Br J Pharmacol; 1993 Apr; 108(4):1100-6. PubMed ID: 8097952
[TBL] [Abstract][Full Text] [Related]
15. NSP4, an elastase-related protease in human neutrophils with arginine specificity.
Perera NC; Schilling O; Kittel H; Back W; Kremmer E; Jenne DE
Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6229-34. PubMed ID: 22474388
[TBL] [Abstract][Full Text] [Related]
16. Kinetics of the inhibition of neutrophil proteinases by recombinant elafin and pre-elafin (trappin-2) expressed in Pichia pastoris.
Zani ML; Nobar SM; Lacour SA; Lemoine S; Boudier C; Bieth JG; Moreau T
Eur J Biochem; 2004 Jun; 271(12):2370-8. PubMed ID: 15182352
[TBL] [Abstract][Full Text] [Related]
17. Inflammation-related neutrophil proteases, cathepsin G and elastase, function as insulin-like growth factor binding protein proteases.
Gibson TL; Cohen P
Growth Horm IGF Res; 1999 Aug; 9(4):241-53. PubMed ID: 10512690
[TBL] [Abstract][Full Text] [Related]
18. Secretory leukocyte protease inhibitor and its potential interactions with elastase and cathepsin B in gingival crevicular fluid and saliva from patients with chronic periodontitis.
Cox SW; Rodriguez-Gonzalez EM; Booth V; Eley BM
J Periodontal Res; 2006 Oct; 41(5):477-85. PubMed ID: 16953825
[TBL] [Abstract][Full Text] [Related]
19. Localisation of secretory leucocyte proteinase inhibitor mRNA in nasal mucosa.
Westin U; Fryksmark U; Polling A; Ohlsson K
Acta Otolaryngol; 1994 Mar; 114(2):199-202. PubMed ID: 7515550
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II generation at the cell surface of activated neutrophils: novel cathepsin G-mediated catalytic activity that is resistant to inhibition.
Owen CA; Campbell EJ
J Immunol; 1998 Feb; 160(3):1436-43. PubMed ID: 9570564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
